JP2020537652A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020537652A5 JP2020537652A5 JP2020521444A JP2020521444A JP2020537652A5 JP 2020537652 A5 JP2020537652 A5 JP 2020537652A5 JP 2020521444 A JP2020521444 A JP 2020521444A JP 2020521444 A JP2020521444 A JP 2020521444A JP 2020537652 A5 JP2020537652 A5 JP 2020537652A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- pharmaceutically acceptable
- acceptable salt
- oligonucleotide conjugate
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)N1CC(*)OC(C)C1 Chemical compound CC(C)N1CC(*)OC(C)C1 0.000 description 2
- PVMNSAIKFPWDQG-UHFFFAOYSA-N CC(C)(C)N1CCNCC1 Chemical compound CC(C)(C)N1CCNCC1 PVMNSAIKFPWDQG-UHFFFAOYSA-N 0.000 description 1
- QJQUFJQKQQYYHZ-UHFFFAOYSA-N CC(C)c(c(F)c(c(-c(c([I]=C)c(c(C(C)C)c1F)F)c1[I]=C)c1F)F)c1F Chemical compound CC(C)c(c(F)c(c(-c(c([I]=C)c(c(C(C)C)c1F)F)c1[I]=C)c1F)F)c1F QJQUFJQKQQYYHZ-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023129042A JP2023138661A (ja) | 2017-10-17 | 2023-08-08 | 二環式ペプチドオリゴヌクレオチドコンジュゲート |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762573473P | 2017-10-17 | 2017-10-17 | |
| US62/573,473 | 2017-10-17 | ||
| PCT/US2018/056178 WO2019079367A1 (en) | 2017-10-17 | 2018-10-17 | OLIGONUCLEOTIDE CONJUGATES-BICYCLIC PEPTIDES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023129042A Division JP2023138661A (ja) | 2017-10-17 | 2023-08-08 | 二環式ペプチドオリゴヌクレオチドコンジュゲート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020537652A JP2020537652A (ja) | 2020-12-24 |
| JP2020537652A5 true JP2020537652A5 (enExample) | 2021-11-11 |
| JP7356416B2 JP7356416B2 (ja) | 2023-10-04 |
Family
ID=66173478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020521444A Active JP7356416B2 (ja) | 2017-10-17 | 2018-10-17 | 二環式ペプチドオリゴヌクレオチドコンジュゲート |
| JP2023129042A Pending JP2023138661A (ja) | 2017-10-17 | 2023-08-08 | 二環式ペプチドオリゴヌクレオチドコンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023129042A Pending JP2023138661A (ja) | 2017-10-17 | 2023-08-08 | 二環式ペプチドオリゴヌクレオチドコンジュゲート |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12502432B2 (enExample) |
| EP (1) | EP3700537A4 (enExample) |
| JP (2) | JP7356416B2 (enExample) |
| TW (1) | TWI816703B (enExample) |
| WO (1) | WO2019079367A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3983794B1 (en) * | 2019-06-14 | 2025-10-22 | Laboratory Corporation of America Holdings | Ion-pairing free lc-ms bioanalysis of oligonucleotides |
| WO2024163762A2 (en) * | 2023-02-01 | 2024-08-08 | Alnylam Pharmaceuticals, Inc. | Six membered ring containing oligomers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2657400T3 (es) | 2006-05-10 | 2018-03-05 | Sarepta Therapeutics, Inc. | Análogos de oligonucleótidos que tienen enlaces intersubunitarios catiónicos |
| US20100016215A1 (en) | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| MX363734B (es) | 2011-10-27 | 2019-03-29 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco. |
| MX369519B (es) * | 2012-09-25 | 2019-11-11 | Genzyme Corp | Oligonucleotidos antisentido morfolino unidos a peptido para el tratamiento de distrofia miotonica. |
| WO2014124952A1 (en) | 2013-02-12 | 2014-08-21 | Syddansk Universitet | "clickable" alkyne-lna oligonucleotides |
| US10675356B2 (en) * | 2015-05-19 | 2020-06-09 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| WO2017066789A1 (en) * | 2015-10-16 | 2017-04-20 | Modernatx, Inc. | Mrna cap analogs with modified sugar |
-
2018
- 2018-10-17 JP JP2020521444A patent/JP7356416B2/ja active Active
- 2018-10-17 US US16/756,435 patent/US12502432B2/en active Active
- 2018-10-17 WO PCT/US2018/056178 patent/WO2019079367A1/en not_active Ceased
- 2018-10-17 EP EP18868378.3A patent/EP3700537A4/en active Pending
- 2018-10-17 TW TW107136579A patent/TWI816703B/zh active
-
2023
- 2023-08-08 JP JP2023129042A patent/JP2023138661A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020537654A5 (enExample) | ||
| JP2018538302A5 (enExample) | ||
| HRP20231431T1 (hr) | Peptidno oligonukleotidni konjugati | |
| JP5271913B2 (ja) | 化合物 | |
| JP2021182946A5 (enExample) | ||
| JP2020503009A5 (enExample) | ||
| JP2025096427A (ja) | 抗ウイルスプロドラッグ及びその製剤 | |
| US7582748B2 (en) | Methods of manufacture of 2′-deoxy-β-L-nucleosides | |
| JP2020503010A5 (enExample) | ||
| JP2018509143A5 (enExample) | ||
| AU780879B2 (en) | Anti-viral pyrimidine nucleoside analogues | |
| CA2904692A1 (en) | Modified 4'-nucleosides as antiviral agents | |
| WO2005021568B1 (en) | Novel tricyclic nucleosides or nucleotides as therapeutic agents | |
| RU2005118421A (ru) | 2'-разветвленные нуклеозиды и мутация flaviviridae | |
| JP2009538829A5 (enExample) | ||
| JP2019088329A5 (enExample) | ||
| CN100335492C (zh) | 生产3’－核苷前体药物的方法 | |
| JP2024038025A (ja) | 癌療法のためのコンジュゲートの塩 | |
| JP2017514479A5 (enExample) | ||
| JP2020537652A5 (enExample) | ||
| CZ295706B6 (cs) | Derivát 5´-deoxycytidinu, způsob jeho výroby a použití a farmaceutická kompozice a kit s jeho obsahem | |
| JP2020525502A5 (enExample) | ||
| EP0356166B1 (en) | Therapeutic nucleosides | |
| US7595390B2 (en) | Industrially scalable nucleoside synthesis | |
| EP0672701A1 (de) | PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe |